| Promising effects of oxytocin on social and food‐related behaviour in young children with Prader–Willi syndrome: a randomized, double‐blind, controlled crossover trial RJ Kuppens, SH Donze, ACS Hokken‐Koelega Clinical endocrinology 85 (6), 979-987, 2016 | 96 | 2016 |
| A transcriptomic signature of the hypothalamic response to fasting and BDNF deficiency in Prader-Willi syndrome EG Bochukova, K Lawler, S Croizier, JM Keogh, N Patel, G Strohbehn, ... Cell reports 22 (13), 3401-3408, 2018 | 90 | 2018 |
| Beneficial effects of GH in young adults with Prader-Willi syndrome: a 2-year crossover trial RJ Kuppens, NE Bakker, EPC Siemensma, ... The Journal of Clinical Endocrinology & Metabolism 101 (11), 4110-4116, 2016 | 48 | 2016 |
| Oxytocin in young children with Prader‐Willi syndrome: Results of a randomized, double‐blind, placebo‐controlled, crossover trial investigating 3 months of oxytocin L Damen, LN Grootjen, AF Juriaans, SH Donze, TM Huisman, JA Visser, ... Clinical Endocrinology 94 (5), 774-785, 2021 | 38 | 2021 |
| The growth response to GH treatment is greater in patients with SHOX enhancer deletions compared to SHOX defects SH Donze, CR Meijer, SG Kant, GRJ Zandwijken, AH Van Der Hout, ... European Journal of Endocrinology 173 (5), 611-621, 2015 | 32 | 2015 |
| Improved mental and motor development during 3 years of GH treatment in very young children with Prader-Willi syndrome SH Donze, L Damen, EF Mahabier, ACS Hokken-Koelega The Journal of Clinical Endocrinology & Metabolism 103 (10), 3714-3719, 2018 | 30 | 2018 |
| Bone mineral density in young adults with Prader‐Willi syndrome: A randomized, placebo‐controlled, crossover GH trial SH Donze, RJ Kuppens, NE Bakker, JAEM van Alfen‐van der Velden, ... Clinical endocrinology 88 (6), 806-812, 2018 | 28 | 2018 |
| Metabolic health profile in young adults with Prader–Willi syndrome: results of a 2‐year randomized, placebo‐controlled, crossover GH trial RJ Kuppens, NE Bakker, EPC Siemensma, SH Donze, T Stijnen, ... Clinical endocrinology 86 (2), 297-304, 2017 | 27 | 2017 |
| Effect of cessation of GH treatment on cognition during transition phase in Prader-Willi syndrome: results of a 2-year crossover GH trial RJ Kuppens, EF Mahabier, NE Bakker, EPC Siemensma, SH Donze, ... Orphanet journal of rare diseases 11, 1-8, 2016 | 27 | 2016 |
| Prevalence of growth hormone (GH) deficiency in previously GH‐treated young adults with Prader‐Willi syndrome SH Donze, L Damen, JAEM van Alfen‐van der Velden, G Bocca, ... Clinical endocrinology 91 (1), 118-123, 2019 | 25 | 2019 |
| Cognitive functioning in children with Prader–Willi syndrome during 8 years of growth hormone treatment SH Donze, L Damen, EF Mahabier, ACS Hokken-Koelega European Journal of Endocrinology 182 (4), 405-411, 2020 | 23 | 2020 |
| Three years of growth hormone treatment in young adults with Prader-Willi syndrome: sustained positive effects on body composition L Damen, SH Donze, RJ Kuppens, NE Bakker, LCG de Graaff, ... Orphanet journal of rare diseases 15, 1-9, 2020 | 22 | 2020 |
| Effects of 8 years of growth hormone treatment on scoliosis in children with Prader–Willi syndrome LN Grootjen, JPHJ Rutges, L Damen, SH Donze, AF Juriaans, GF Kerkhof, ... European Journal of Endocrinology 185 (1), 47-55, 2021 | 20 | 2021 |
| Sleep-related breathing disorders in young adults with Prader-Willi syndrome: a placebo-controlled, crossover GH trial SH Donze, AW de Weerd, RAS van den Bossche, KFM Joosten, ... The Journal of Clinical Endocrinology & Metabolism 104 (9), 3931-3938, 2019 | 16 | 2019 |
| Three years of growth hormone treatment in young adults with Prader‐Willi Syndrome previously treated with growth hormone in childhood: Effects on glucose homeostasis and … L Damen, LN Grootjen, SH Donze, AF Juriaans, LCG de Graaff, ... Clinical Endocrinology 93 (4), 439-448, 2020 | 13 | 2020 |
| Complementing the phenotypical spectrum of TUBA1A tubulinopathy and its role in early-onset epilepsies J Schröter, B Popp, H Brennenstuhl, JH Döring, SH Donze, EK Bijlsma, ... European Journal of Human Genetics 30 (3), 298-306, 2022 | 10 | 2022 |
| Free insulin-like growth factor (IGF)-I in children with PWS L Damen, MSM Elizabeth, SH Donze, SAA van den Berg, LCG de Graaff, ... Journal of Clinical Medicine 11 (5), 1280, 2022 | 7 | 2022 |
| Evidence for accelerated biological aging in young Adults with Prader–Willi syndrome SH Donze, V Codd, L Damen, WJ Goedegebuure, M Denniff, NJ Samani, ... The Journal of Clinical Endocrinology & Metabolism 105 (6), 2053-2059, 2020 | 7 | 2020 |
| Bone mineral density during 3 years of growth hormone in previously GH-treated young adults with PWS L Damen, LN Grootjen, SH Donze, LCG de Graaff, JAEM van der Velden, ... European Journal of Endocrinology 184 (6), 773-782, 2021 | 6 | 2021 |
| A transcriptomic signature of the hypothalamic response to fasting and BDNF deficiency in Prader-Willi Syndrome. Cell Rep 22: 3401–3408 EG Bochukova, K Lawler, S Croizier, JM Keogh, N Patel, G Strohbehn, ... | 6 | 2018 |
